SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlowtech Fluid. Regulatory News (FLO)

Share Price Information for Flowtech Fluid. (FLO)

Share Price is delayed by 15 minutes
Get Live Data
54.60    -1.40 (-2.50%)
Bid:
52.60
Ask:
56.60
Spread: 4.00 (7.605%)
Market Cap: £45.60m
FLO Live PriceLast checked at - London Stock Exchange

Intraday Flowtech Fluid. Share Chart

Offer Rejection

9 May 2008 08:48

Flomerics Group PLC09 May 2008 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN FOR IMMEDIATE RELEASE 9 May 2008 FLOMERICS GROUP PLC Statement re: Unsolicited Offer The Board of Directors of Flomerics Group PLC ("Flomerics" or the "Company")notes the statement by Mentor Graphics, Inc. ("Mentor") indicating that itintends to make a public offer for all the outstanding shares and stock optionsin Flomerics at a price of 104 pence per share payable in cash (the "Offer"). The Board of Directors of Flomerics believes the Offer undervalues the Companyand intends to analyse other alternatives available to the Company, includingpotential interest expressed by a number of other parties. David Mann, the Chairman of the Board of Flomerics commented: "The Offer wasconsidered by the Board of Flomerics, in conjunction with its independentadvisers, and it was unanimously concluded that this Offer, which isunsolicited, does not reflect the true value of Flomerics shares. As such, theOffer does not carry the recommendation of the Flomerics Board of Directors as,at this stage, we do not believe it is in the best interests of Flomericsshareholders". Any discussions with other interested parties are at a preliminary stage andthere can be no certainty that an alternative offer will be forthcoming.However, shareholders are strongly recommended to take no action at this stage.A further announcement will be made in due course. Enquiries: Flomerics Group PLC Tel: 020 8487 3000 Gary Carter Keith Butcher Jefferies International Ltd Tel: 020 7029 8000 Andres Pieczanski Sarah McNicholas Oriel Securities Ltd Tel: 020 7710 7600 Andrew Edwards Michael Shaw Citigate Dewe Rogerson Tel: 020 7638 9571 Ginny Pulbrook Pursuant to Rule 2.10 of the City Code, Flomerics confirms that it has22,857,450 ordinary shares of one penny each in issue and admitted to trading onthe Alternative Investment Market of the London Stock Exchange (ISINGB0003436192). Dealing Disclosure Requirements Under the provisions of Rule 8.3 of the Takeover Code (the "Code"), if anyperson is, or becomes, "interested" (directly or indirectly) in 1% or more ofany class of "relevant securities" of Flomerics, all "dealings" in any "relevantsecurities" of that company (including by means of an option in respect of, or aderivative referenced to, any such "relevant securities") must be publiclydisclosed by no later than 3.30 pm (London time) on the London business dayfollowing the date of the relevant transaction. This requirement will continueuntil the date on which the offer becomes, or is declared, unconditional as toacceptances, lapses or is otherwise withdrawn or on which the "offer period"otherwise ends. If two or more persons act together pursuant to an agreement orunderstanding, whether formal or informal, to acquire an "interest" in "relevantsecurities" of Nestor, they will be deemed to be a single person for the purposeof Rule 8.3. Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevantsecurities" of Flomerics by a potential offeror or by Flomerics, or by any oftheir respective "associates", must be disclosed by no later than 12.00 noon(London time) on the London business day following the date of the relevanttransaction. A disclosure table, giving details of the companies in whose "relevantsecurities" "dealings" should be disclosed, and the number of such securities inissue, can be found on the Takeover Panel's website atwww.thetakeoverpanel.org.uk. "Interests in securities" arise, in summary, when a person has long economicexposure, whether conditional or absolute, to changes in the price ofsecurities. In particular, a person will be treated as having an "interest" byvirtue of the ownership or control of securities, or by virtue of any option inrespect of, or derivative referenced to, securities. Terms in quotation marks are defined in the Code, which can also be found on thePanel's website. If you are in any doubt as to whether or not you are requiredto disclose a "dealing" under Rule 8, you should consult the Panel. Note to Editors Flomerics (www.flomerics.com) is a world-leading developer of engineeringsimulation software and services for analysis of fluid flow, heat transfer.Flomerics' business model is drastically different from traditional analysisbecause its software is designed to be embedded deeply into the design processand used by mainstream design engineers, not just by analysis specialists. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Jun 20087:00 amRNSStatement re Unsolicited Offe
30th May 20084:40 pmRNSOffer Update
30th May 20082:36 pmRNSRule 2.10 Announcement
30th May 20089:30 amRNSAdditional Listing
29th May 20081:41 pmRNSResult of AGM
28th May 20082:15 pmRNSResult of AGM
28th May 20082:11 pmRNSPosting of Defence Document
28th May 20087:00 amRNSOffer Update
27th May 20087:00 amRNSQ1 Trading Update
19th May 20081:30 pmRNSStatement
19th May 20087:00 amRNSOffer Document Posted
16th May 20087:00 amRNSAnnual General Meeting
13th May 20081:20 pmRNSRule 8.3-Flomerics Plc
13th May 200812:45 pmRNSRule 8.3- Flomerics Group Plc
13th May 20089:35 amRNSRule 2.10 and TVR
12th May 20081:49 pmRNSAdditional Listing
9th May 20088:48 amRNSOffer Rejection
9th May 20088:37 amRNSOffer for Flomerics Group plc
30th Apr 20084:23 pmRNSHolding(s) in Company
30th Apr 200811:14 amRNSAdditional Listing
29th Apr 20087:01 amRNSFinal Results
18th Apr 200812:06 pmRNSAdditional Listing
15th Apr 200810:41 amRNSDirectorate Change
10th Apr 20082:51 pmRNSHolding(s) in Company
10th Apr 20087:00 amRNSTotal Voting Rights
27th Mar 20087:02 amRNSUpdate
19th Mar 200812:58 pmRNSHolding(s) in Company
19th Mar 200810:11 amRNSHolding(s) in Company
18th Mar 20083:59 pmRNSAdditional Listing
18th Mar 20087:30 amRNSHolding(s) in Company
17th Mar 200811:27 amRNSHolding(s) in Company
14th Mar 20083:17 pmRNSHolding(s) in Company
3rd Mar 20087:00 amRNSAdditional Listing
28th Feb 20082:37 pmRNSDirector/PDMR Shareholding
27th Feb 200810:50 amRNSDirector/PDMR Shareholding
22nd Feb 20085:31 pmRNSDirector/PDMR Shareholding
21st Feb 200812:19 pmRNSGrant of Options
9th Jan 20087:00 amRNSTrading Statement
20th Dec 20077:02 amRNSDisposal
19th Dec 200712:36 pmRNSHolding(s) in Company
3rd Dec 200712:00 pmRNSDirectorate Change
27th Sep 200711:23 amRNSAdditional Listing
27th Sep 20079:41 amRNSHolding(s) in Company
19th Sep 20077:02 amRNSInterim Results
14th Sep 20075:03 pmRNSHolding(s) in Company
15th Aug 20072:27 pmRNSAIM Rule 26
13th Jul 20077:00 amRNSTrading Statement
12th Jul 20075:07 pmRNSHolding(s) in Company
5th Jul 200711:41 amRNSTotal Voting Rights
21st Jun 20075:52 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.